Evidence map›Paper›PMID 38906652›Full record

ArticleKidney international2024

Genomics in the kidney transplant clinic: the future standard of care?

Emilie Cornec-Le Gall, Andrew J Mallett

Abstract readComment
PubMed Publisher
In one paragraph

Article in Kidney international, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

2 authors.

Emilie Cornec-Le GallUniversity of Brest, Inserm, Unité Mixte de Recherche (UMR) 1078, Génétique, Génomique fonctionnelle et Biotechnologies (GGB), Brest, France; Centre Hospitalier Universitaire (CHU) Brest, Service de Néphrologie, Centre de Référence Maladies Rénales Héréditaires de l'Enfant et de l'Adulte (MARHEA), Brest, France. Electronic address: emilie.cornec-le-gall@inserm.fr.
Andrew J MallettDepartment of Renal Medicine, Townsville University Hospital, Douglas, Queensland, Australia; College of Medicine and Dentistry, James Cook University, Douglas, Queensland, Australia; Institute for Molecular Bioscience, The University of Queensland, St Lucia, Queensland, Australia. Electronic address: andrew.mallett@health.qld.gov.au.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

New evidence indicates potential benefit of genomics to illuminate nonkidney monogenic morbidity and mortality risk among kidney transplant recipients. This might be of direct relevance to an equivalent proportion of patients to those who harbor a monogenic kidney disease. Further evidence and replication are indicated, including a broadening potential range of monogenic and polygenic opportunities to improve clinical outcomes. Implementation will require such information, although it holds great promise.

Indexed as

GenomicsKidney TransplantationGenetic Predisposition to DiseaseHumansKidney DiseasesStandard of Care

Identifiers

PMID38906652

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.